Well Done »

Rani Therapeutics Hldgs shares owned by Well Done

Quarter-by-quarter ownership of Rani Therapeutics Hldgs (RANI) shares owned by Well Done from 13F filings

Historical chart of Well Done investment in Rani Therapeutics Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Rani Therapeutics Hldgs held by Well Done consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rani Therapeutics Hldgs by Well Done

Quarter filed Position value Share count Share price at filing
2025-09-30 $26k 52k 0.50
2025-06-30 $27k 52k 0.51

More positions owned by Well Done

Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Core S&p500 Etf (IVV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Tr Msci Usa Min Vol (USMV)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Core Div Grwth (DGRO)
Dimensional Etf Trust Us Small Cap Val (DFSV)
Ishares Tr Msci Usa Mmentm (MTUM)
Gentex Corporation (GNTX)
Ishares Gold Tr Ishares New (IAU)
Abbvie (ABBV)
Ishares Tr Core S&p Ttl Stk (ITOT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Us Br Del Se Etf (IAI)
Ishares Tr Us Aer Def Etf (ITA)

View all positions for Well Done

Top funds holding Rani Therapeutics Hldgs

Vanguard Group
Nan Fung Group Holdings
Citadel Advisors
United Services Automobile Association
Geode Capital Management
Kestra Private Wealth Services
Takeda Pharmaceutical
CWA Asset Management
BlackRock
Hrt Financial
Northern Trust
UBS Group
Marc Lasry
State Street Corporation
Luther King Capital Management Corporation

View all funds holding Rani Therapeutics Hldgs